RGT 2.90% 35.5¢ argent biopharma limited

Ann: Trading Halt, page-30

  1. 1,377 Posts.
    lightbulb Created with Sketch. 1
    Well im assuming their running clinical trails on our strain/IP'd version of the MM - if we have one.

    There wouldn't be much point, rather than the public good etc, in running just a general trial of someone elses weed id imagine.

    The best thing would to be use our specific strain/compounds and prove them through multiple stages of trials, then to be approved for domestic use in AUS/Europe/USA/WORLD - that is the $$$.

    IMO.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.